| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.78B | 3.65B | 3.54B | 3.09B | 3.38B | 2.68B |
| Gross Profit | 1.81B | 1.74B | 1.71B | 1.42B | 1.42B | 1.20B |
| EBITDA | 846.51M | 893.87M | 913.55M | 794.03M | 795.27M | 787.26M |
| Net Income | 423.19M | 460.80M | 530.43M | 448.06M | 468.13M | 557.24M |
Balance Sheet | ||||||
| Total Assets | 6.67B | 6.85B | 6.50B | 5.48B | 5.01B | 5.01B |
| Cash, Cash Equivalents and Short-Term Investments | 1.87B | 1.66B | 1.08B | 960.11M | 1.57B | 1.74B |
| Total Debt | 1.15B | 1.32B | 1.27B | 568.45M | 233.87M | 123.93M |
| Total Liabilities | 2.43B | 2.80B | 2.54B | 1.70B | 1.33B | 1.36B |
| Stockholders Equity | 4.12B | 4.03B | 3.97B | 3.78B | 3.67B | 3.65B |
Cash Flow | ||||||
| Free Cash Flow | 298.61M | 403.85M | 966.59M | 273.38M | 282.47M | 511.94M |
| Operating Cash Flow | 425.38M | 527.30M | 1.10B | 653.69M | 598.55M | 773.29M |
| Investing Cash Flow | -261.52M | -306.29M | -1.21B | -1.18B | -280.05M | -190.78M |
| Financing Cash Flow | -553.13M | -471.60M | 227.99M | -90.43M | -482.92M | -590.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$51.09B | 12.86 | 23.92% | 6.15% | 5.51% | 3.90% | |
76 Outperform | HK$19.40B | 11.48 | 14.24% | 5.87% | 14.76% | 23.04% | |
69 Neutral | HK$4.05B | 8.86 | 10.67% | 8.21% | 3.23% | -21.82% | |
68 Neutral | HK$2.61B | 8.79 | 2.91% | 5.01% | -2.56% | ― | |
63 Neutral | HK$996.20M | 30.90 | 2.21% | 1.28% | -14.05% | 20.05% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$723.83M | 7.06 | 4.94% | 6.04% | 0.72% | 2.24% |
China Lilang Limited reported that retail sales of its LILANZ-branded products grew by a high single digit in value terms in the fourth quarter of 2025 compared with the same period a year earlier, underscoring resilient consumer demand for its menswear offerings. For the full year of 2025, retail sales increased by a low double digit over 2024, signaling a solid top-line expansion for the brand, although the company cautioned that these preliminary, unaudited operational figures do not directly reflect overall revenue or profit performance and may be subject to adjustment, advising shareholders and potential investors to remain cautious in trading its shares.
The most recent analyst rating on (HK:1234) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on China Lilang Ltd. stock, see the HK:1234 Stock Forecast page.
China Lilang Ltd. reported a low double-digit increase in retail sales for its LILANZ products in the third quarter of 2025 compared to the same period in 2024. This operational update, based on preliminary unaudited data, suggests a positive trend in the company’s retail performance, though stakeholders are advised to exercise caution as the figures are subject to change.
The most recent analyst rating on (HK:1234) stock is a Buy with a HK$4.00 price target. To see the full list of analyst forecasts on China Lilang Ltd. stock, see the HK:1234 Stock Forecast page.